RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Jorge Duconge to United States Food and Drug Administration

Back to Details
This is a "connection" page, showing publications Jorge Duconge has written about United States Food and Drug Administration.
Jorge Duconge
Connection Strength
0.230
United States Food and Drug Administration
  1. Duconge J, Rua?o G. Preventing the exacerbation of health disparities by iatrogenic pharmacogenomic applications: lessons from warfarin. Pharmacogenomics. 2018 07 01; 19(11):875-881.
    View in: PubMed
    Score: 0.160
  2. Duconge J. The case of biotech-derived product equivalence: much ado about nothing? Curr Clin Pharmacol. 2006 May; 1(2):147-56.
    View in: PubMed
    Score: 0.069
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support